TWST vs VCYT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TWST Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Momentum & Technical, Options & Structure while VCYT counters with relative strength in Valuation, Growth & Margin. Fundamentally, TWST trades at N/M Forward P/E with -28.8% operating margin (+27.9% YoY revenue) versus VCYT at 15.3x Forward P/E and 15.0% operating margin (+15.1% YoY). In options structure, TWST sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro) against VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TWST Revenue | VCYT Revenue | TWST Op. Margin | VCYT Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $30M | $90M | -277.5% | -24.2% | VCYT |
| FY2019 | $50M | $120M | -200.1% | -12.6% | VCYT |
| FY2020 | $90M | $120M | -155.5% | -30.1% | VCYT |
| FY2021 | $130M | $220M | -115.4% | -37.3% | VCYT |
| FY2022 | $200M | $300M | -115.3% | -13.9% | VCYT |
| FY2023 | $250M | $360M | -88.6% | -23.8% | VCYT |
| FY2024 | $310M | $450M | -70.6% | 3.6% | VCYT |
| FY2025 | $380M | $520M | -36.2% | 11.2% | VCYT |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TWST | VCYT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.4B | $2.0B | Larger Scale | TWST |
| Trailing P/E Ratio Valuation | N/M | 15.8x | Lower Multiple | VCYT |
| Forward P/E Ratio Valuation | N/M | 15.3x | Lower Multiple | VCYT |
| Revenue Growth (YoY) Growth | +27.9% | +15.1% | Higher Growth | TWST |
| Operating Margin (TTM) Profitability | -28.8% | 15.0% | Higher Margin | VCYT |
| Net Profit Margin Profitability | -28.3% | 21.8% | Higher Margin | VCYT |
| Return on Equity (ROE) Capital Efficiency | -19.1% | 9.4% | Higher ROE | VCYT |
| 52-Week Range Position Momentum | 42% ($23โ$220) | 5% ($22โ$61) | Stronger Trend | TWST |
| Beta / 30D Volatility Risk Regime | 3.13ฮฒ ยท 126% Vol | 3.01ฮฒ ยท 199% Vol | Lower Realized Risk | TWST |
| Unified Institutional Score Composite Signal | 51.7 / 100 (HOLD) | 49.1 / 100 (HOLD) | Higher Composite | TWST |